U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417943) titled 'Neuromodulation to Enhance Motor Function in HSP' on Feb. 10.
Brief Summary: Hereditary spastic paraplegia (HSP) is a rare neurological condition that causes stiffness, weakness, and difficulty walking due to damage in the nerves that control movement. This study will test whether a noninvasive form of spinal cord stimulation, called transcutaneous spinal cord stimulation (tSCS), can improve walking and reduce muscle stiffness in adults with HSP.
In this study, participants will receive tSCS twice a week for 8 weeks. The stimulation is delivered through self-adhesive electrodes placed on the skin over the lower back and does not re...